Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Share-based Compensation (2016 - 2025)

iBio (IBIO) has disclosed Share-based Compensation for 16 consecutive years, with $253000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 46.74% to $253000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 28.64% year-over-year, with the annual reading at $1.5 million for FY2025, 24.93% down from the prior year.
  • Share-based Compensation for Q4 2025 was $253000.0 at iBio, down from $323000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $2.0 million in Q2 2023, with the low at $253000.0 in Q4 2025.
  • Average Share-based Compensation over 5 years is $677950.0, with a median of $464500.0 recorded in 2023.
  • The sharpest move saw Share-based Compensation surged 493.65% in 2021, then crashed 81.68% in 2024.
  • Over 5 years, Share-based Compensation stood at $960000.0 in 2021, then dropped by 4.69% to $915000.0 in 2022, then tumbled by 50.38% to $454000.0 in 2023, then increased by 4.63% to $475000.0 in 2024, then plummeted by 46.74% to $253000.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $253000.0, $323000.0, and $270000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.